In vivo ADME and PK studies

High value on client communication

We offer a rapid Non-GLP discovery rodent in vivo ADME pharmacokinetics (PK) and bioanalysis. We engage with clients to help design the most appropriate study format tailored to our clients’ requirements. In-life phases are delivered through our trusted partners and the samples are then returned to Concept Life Sciences for full bioanalysis.

Our CRO services place a high value on client communication during all phases of a study. We engage with clients at each stage of the process to deliver high quality and timely data whether it be a discovery-phase screen or a complex and unique in vivo study.

In vivo ADME PK capabilities

In vivo ADME PK capabilities

  • Bioanalytical method development and validation
  • Highly flexible study design and readouts
  • Formulation studies
  • Highly flexible dosing routes
  • Array of sampling techniques & matrices
  • Determination of PK parameters (Phoenix WinNonLin software)

Laboratories are GLP accredited

In addition to bioanalytical determinations, our labs also support biomarker assays and in vivo biotransformation. Concentration data is also further processed to provide pharmaco and toxicokinetic information using industry standard Phoenix WinNonLin software.

Our regulatory bioanalytical laboratories are GLP accredited and as such have the capability to develop and validate fully compliant methodologies in support of GLP TK studies.

Want to find out more?

Our multi-disciplinary teams mitigate risk by employing knowledge, foresight and thought leadership to all our client’s diverse programs enabling the highest chance of success. Get in touch to find out how we can support you.